WORTHY WALKER ARRINGTON
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family JACKSON, TN NPI 1659797702
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TN Acerta Pharma LLC All categories
General Payments — all program years on this page
$3,427.24
- Category: General Payments
- Program years: PY2021–2024
- Record count: 157
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,330.32 across 60 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,231.36 | 59 |
| Education | $98.96 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $119.96 | 2 |
| Merck Sharp & Dohme Corporation | $110.96 | 5 |
| PFIZER INC. | $106.14 | 6 |
| E.R. Squibb & Sons, L.L.C. | $99.88 | 6 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $99.65 | 4 |
| Daiichi Sankyo Inc. | $83.25 | 3 |
| Janssen Biotech, Inc. | $72.78 | 4 |
| EISAI INC. | $67.13 | 3 |
| GlaxoSmithKline, LLC. | $59.51 | 3 |
| Lilly USA, LLC | $40.43 | 2 |
| AVEO Pharmaceuticals, Inc. | $40.28 | 1 |
| Genentech USA, Inc. | $39.21 | 2 |
| SpringWorks Therapeutics, Inc. | $30.56 | 1 |
| SERVIER PHARMACEUTICALS LLC | $30.19 | 2 |
| Genmab U.S., Inc. | $25.17 | 1 |
| Stemline Therapeutics Inc. | $24.09 | 1 |
| GENZYME CORPORATION | $23.55 | 1 |
| JAZZ PHARMACEUTICALS INC. | $22.82 | 1 |
| Gilead Sciences, Inc. | $22.44 | 1 |
| Legend Biotech USA Inc. | $21.93 | 1 |
| Astellas Pharma US Inc | $20.66 | 1 |
| Tempus AI, Inc | $20.31 | 1 |
| Alexion Pharmaceuticals, Inc. | $20.25 | 1 |
| Celgene Corporation | $19.82 | 1 |
| Azurity Pharmaceuticals, Inc. | $19.19 | 1 |
| Regeneron Healthcare Solutions, Inc. | $18.75 | 1 |
| ABBVIE INC. | $18.67 | 1 |
| Incyte Corporation | $18.29 | 1 |
| TerSera Therapeutics LLC | $17.49 | 1 |
| TAIHO ONCOLOGY, INC. | $16.96 | 1 |
By program year
Records — PY2024 (60)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.